DFDA

Rezum Water Vapor Thermal Therapy

Treatment for Benign Prostatic Hyperplasia

Effectiveness
70%
Safety Score
52%
Clinical Trials
16
Participants
4K

Comparative Safety Scale(Higher is safer)

Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
52
DangerousModerateSafe
Treatment Details
Time to Effect
2 weeks (initial) to 3 months (full effect)
Treatment Duration
Single procedure (effects >4 years)
Evidence Quality
HIGH
Number Needed to Treat (NNT)
3(Treat 3 patients to see 1 additional successful outcome)
Number Needed to Harm (NNH)
4(Treat 4 patients to see 1 additional serious adverse event)
Confidence Score
88%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$0
Monitoring:$200
Side Effect Mgmt:$100
Total Annual:$2,050
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENT
ICER
$35,000/QALY
QALYs Gained
0.09
Outcome-Based Costs
Cost per Responder
$2,733
Comparison vs TURP
Cost Difference
$-2,000/year
Less expensive
QALY Difference
+0.05 QALYs
Better outcomes
Dominance
DOMINATESBetter + cheaper
Rezum Water Vapor Thermal Therapy Outcomes

for Benign Prostatic Hyperplasia

Efficacy Outcomes
Overall Effectiveness
+70%
Response Rate
+75%
Common Side Effects
Dysuria
+25%
Urinary retention (temporary, catheterization)
+15%
Hematuria
+15%
Urgency
+7%
Pelvic pain
+7%

WARNING: LIMITED TRIALS AVAILABLE

You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!

Active Clinical Trials
11 active trials recruiting for Rezum Water Vapor Thermal Therapy in Benign Prostatic Hyperplasia

Study on Water Vapor Thermal Therapy

NCT06656689RECRUITING
View Study
300 participants
OBSERVATIONAL
Suwon, South Korea
Started: Jul 31, 2023

Optimized Water Vapor Thermal Therapy for Benign Prostatic Hyperplasia

NCT06607094NOT YET RECRUITINGNA
View Study
58 participants
INTERVENTIONAL
Started: Sep 1, 2024

Modified Water Vapor Thermal Therapy in Management of Patients With Large-volume Benign Prostatic Hyperplasia

NCT06596590NOT YET RECRUITINGNA
View Study
76 participants
INTERVENTIONAL
Nanjing, China
Started: Sep 1, 2024

Clinical Study on Prostate Thermal Vapor Ablation Guided by MRI/TRUS Fusion Imaging

NCT06817733RECRUITINGNA
View Study
30 participants
INTERVENTIONAL
Beijing, China
Started: Apr 15, 2025

Comparison Between Water Vapor Thermal Therapy and Prostatic Artery Embolization in Treatment of Benign Prostatic Hyperplasia

NCT07416227RECRUITINGNA
View Study
30 participants
INTERVENTIONAL
Cairo, Egypt
Started: Oct 1, 2025

Trial to Assess the Efficacy and Safety During Convective Radiofrequency Water Vapor Thermal Therapy (REZUM) for Benign Prostate Hyperplasia

NCT07017452NOT YET RECRUITINGPHASE3
View Study
48 participants
INTERVENTIONAL
Winnipeg, Canada
Started: Aug 1, 2025

Water Vapor Thermal Therapy Versus Ejaculation-Preserving HoLEP for Benign Prostatic Hyperplasia

NCT07648875RECRUITINGNA
View Study
120 participants
INTERVENTIONAL
Banī Suwayf, Egypt
Started: Jun 8, 2026

Evaluation of the Optilume BPH Catheter System and the Rezum Water Vapor Therapy in Treating Benign Prostatic Hyperplasia

NCT06769997RECRUITINGNA
View Study
100 participants
INTERVENTIONAL
Montreal, Canada
Started: May 9, 2025

Comparing UroLift Experience Against Rezūm

NCT04338776ACTIVE NOT RECRUITINGNA
View Study
120 participants
INTERVENTIONAL
Los Angeles, United States +9 more
Started: Jan 22, 2021

Water Vapor Thermal Therapy Versus Ejaculation-Sparing Bipolar Transurethral Enucleation for Benign Prostatic Hyperplasia

NCT07648888RECRUITINGNA
View Study
120 participants
INTERVENTIONAL
Banī Suwayf, Egypt
Started: Jun 8, 2026

Comparing Rezum and Urolift

NCT06820606RECRUITINGNA
View Study
120 participants
INTERVENTIONAL
Hong Kong, Hong Kong
Started: Jan 1, 2025
Completed Clinical Trials
8 completed trials for Rezum Water Vapor Thermal Therapy in Benign Prostatic Hyperplasia

Safety, Efficacy, and Short-Term Outcomes of Rezūm Water Vapor Thermal Therapy for Benign Prostatic Hyperplasia Under Local Anesthesia With Intravenous Sedation: A Single-Center Retrospective Study of 129 Patients in the Kurdistan Region of Iraq

NCT07507591COMPLETED
View Study
129 participants
OBSERVATIONAL
Sulaymaniyah, Iraq
Started: Sep 3, 2025

One-year Results After Single-center Water Vapor Thermal Therapy for Symptomatic Benign Prostatic Hyperplasia.

NCT06257654COMPLETED
View Study
71 participants
OBSERVATIONAL
Istanbul, Turkey (Türkiye) +1 more
Started: Jan 1, 2021

Rezum I Pilot Study for Benign Prostatic Hyperplasia

NCT02943070COMPLETEDNA
View Study
50 participants
INTERVENTIONAL
Brno, Czechia +2 more
Started: Mar 1, 2012

Long Term Follow up of Water Vapor Thermal Therapy (Rezum) for Benign Prostatic Hyperplasia (BPH)

NCT05982444COMPLETEDNA
View Study
86 participants
INTERVENTIONAL
Helwan, Egypt
Started: Mar 1, 2021

Rezum FIM Optimization Study

NCT02940392COMPLETEDNA
View Study
15 participants
INTERVENTIONAL
La Romana, Dominican Republic
Started: Mar 19, 2012

Holmium Laser Enucleation Of the Prostate Versus Water Vapor Therapy Of The Prostate on Sexual Function and Ejaculation

NCT07566689COMPLETEDNA
View Study
110 participants
INTERVENTIONAL
Banī Suwayf, Egypt
Started: Apr 3, 2024

Comparative Study Between Rezum and Tamsulosin

NCT07169773COMPLETEDNA
View Study
94 participants
INTERVENTIONAL
Cairo, Egypt
Started: May 1, 2022

Comparing Water Vapour Thermal Therapy (Rezūm) and TURP

NCT05762198COMPLETEDNA
View Study
108 participants
INTERVENTIONAL
Hong Kong, Hong Kong
Started: May 1, 2023
Showing 20 of 22 total trials